Button Capital

Button Capital is a venture capital firm based in Mountain View, California, specializing in early-stage investments in the life sciences and medical technology sectors. The firm serves as a strategic partner for companies looking to enter the Chinese market, offering a unique approach to commercialization that combines capital with strategic partnerships. Button Capital focuses on areas such as treatment and diagnosis in women's health, cardiovascular disease, orthopedics, and cancer. It operates through three main areas: an investment arm that nurtures early-stage ventures, an advisory service that assists entrepreneurs in navigating the Chinese market, and Button Analytics, which provides essential data-driven insights for deal sourcing and market trend analysis. The firm is committed to fostering innovation in life sciences and medical technology to meet pressing healthcare needs.

Xi Fang

Founding Partner

Leroy Li

Managing Partner

6 past transactions

Xcision Medical Systems

Series B in 2021
Xcision Medical Systems, LLC is a medical technology company developing advanced stereotactic radiotherapy solutions with the potential to dramatically raise the quality of treatments and improve the lives of patients and their loved ones.

Quest Genomics

Series C in 2020
Quest Genomics is a biotechnology research and development company. They provide products that include digital PCR and NGS-related equipment, consumables, and reagents for clinical testing equipment. Their customers' inquiries are addressed through phone, email, and online applications.

Epintek

Series B in 2020
Epintek develops the biomedical and medical device sectors and offers preclinical research, inspection, and testing, as well as integrated regulatory services, including registration and clinical trial CROs.

Sinorda Biomedicine

Series A in 2019
Sinorda Biomedicine develops medicine and the industrialization of tumor immunotherapy. Their disease treatment program includes anti-tumor sentinel lymph node t-cell therapy, oncolytic virus therapy, tumor-infiltrating t-cell therapy, natural killer cell therapy, dendritic cell therapy, killer t-cell therapy, and tumor immune index monitoring. They also provide immune cell isolation and cryopreservation, accurate genetic testing, and immune function test.

iBanker

Seed Round in 2018
iBanker is a Education Management Startup Based in Beijing.

Lakebio

Seed Round in 2017
LAKEbio to provide a series of liquid biopsies preservation products based on gene detection and other new technologies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.